Albuterol Sulfate
Product Images NDC 54868-5709

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate (NDC 54868-5709). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

F:\daisy Assignment\6月份\06.20\albuterol-sulfate-inhalation-solution-6-20-2008\figure-01.jpg (8f9ecb0b Figure 01)

Chemical structure of Albuterol Sulfate depicting its molecular arrangement including the aromatic ring, hydroxyl groups, and sulfate component as shown.*

FDA Label Image

F:\daisy Assignment\6月份\06.20\albuterol-sulfate-inhalation-solution-6-20-2008\figure-02.jpg (8f9ecb0b Figure 02)

A line graph titled '% Change from Pre-Dose FEV1 Intent-to-Treat Population Day 1,' showing percentage change on the y-axis and hours from pre-dose (0.00 to 6.00) on the x-axis. It compares three treatments: albuterol 1.25 mg, albuterol 0.63 mg, and placebo, illustrating their effects over six hours post-dose.*

FDA Label Image

F:\daisy Assignment\6月份\06.20\albuterol-sulfate-inhalation-solution-6-20-2008\figure-03.jpg (8f9ecb0b Figure 03)

A line chart titled '% Change from Pre-Dose FEV1, Intent-to-Treat Population Day 28' showing percentage change in FEV1 over 6 hours from pre-dose for three treatments: albuterol 1.25 mg, albuterol 0.63 mg, and placebo. The chart illustrates changes declining over time for both albuterol doses with placebo remaining relatively flat.*

FDA Label Image

F:\daisy Assignment\6月份\06.20\albuterol-sulfate-inhalation-solution-6-20-2008\figure-04.jpg (8f9ecb0b Figure 04)

An instructional diagram showing assembly steps for a medical inhalation device. A hand is connecting a mouthpiece to the base of the device, and a medication canister labeled 'Albuterol' is being inserted into the inhaler base.*

FDA Label Image

F:\daisy Assignment\6月份\06.20\albuterol-sulfate-inhalation-solution-6-20-2008\figure-05.jpg (8f9ecb0b Figure 05)

Illustration showing the assembly or connection of components in a device, possibly an inhaler or nebulizer related to Albuterol Sulfate, depicting a hand holding one part and connecting it to another component.*

FDA Label Image

F:\daisy Assignment\6月份\06.20\albuterol-sulfate-inhalation-solution-6-20-2008\figure-06.jpg (8f9ecb0b Figure 06)

An instructional diagram showing a person using a metered-dose inhaler with a spacer device. The illustration demonstrates the proper positioning of the inhaler and spacer at the mouth for inhalation, likely related to the administration of Albuterol Sulfate.*

FDA Label Image

F:\daisy Assignment\6月份\06.20\albuterol-sulfate-inhalation-solution-6-20-2008\figure-07.jpg (8f9ecb0b Figure 07)

An instructional diagram showing a person using a nasal spray device. The illustration focuses on the positioning of the spray nozzle in one nostril and the user's hand pressing the pump to dispense the medication.*

FDA Label Image

Image Of Package Label (Package Label)

Label for Albuterol Sulfate 0.042% inhalation solution, 3 mL, distributed by Physicians Total Care, Inc., Tulsa, OK. The label includes a lot number and an expiration date of 01/60, and the manufacturer is identified as Nephron Pharmaceuticals Co., Orlando, FL. A barcode and the NDC 54868-5709-0 are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.